logo-icon-img
Ctrl+K

Levalbuterol HCL Solution

Closed — responses were due 18 Apr 2022 · Unrestricted (full and open) · Defense Logistics Agency (DLA), DoD · NAICS 325412 · Solicitation SPE2D221R0116

Following NAICS 325412? Get new solicitations in it by email as they post — no account needed.

Email me new ones

A newer version of this notice has been posted. SAM.gov republished solicitation SPE2D221R0116 on 05 August 2025. This page is kept because it is a real record, but the current requirement, dates and attachments are on the latest version. Read the latest version →

What happened next

This solicitation has closed — responses were due 18 April 2022.

SAM.gov has posted 2 award notices for this solicitation. The latest: Teva Pharmaceuticals USA, Inc. Parsippany NJ 07054 USA for $5.7M, posted 23 August 2023. Read the award notice →

Solicitation details

Solicitation numberSPE2D221R0116
Notice ID18344f562fae415fb53b28c0c12410b8
AgencyDepartment of Defense (DoD)
Sub-agencyDefense Logistics Agency (DLA)
Contracting officeDLA TROOP SUPPORT
NAICS code325412 — Pharmaceutical Preparation Manufacturing
Product / service code (PSC)6505
Set-asideUnrestricted (full and open)
Notice typeSolicitation
Posted01 April 2022
Response deadline18 April 2022 (closed)

Get new NAICS 325412 solicitations by email

This one has closed. We'll email you when new NAICS 325412 (Pharmaceutical Preparation Manufacturing) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.

Description

Amendment 0005 is issued to extend the closing date from April 04, 2022 to April 18, 2022 3:00 PM EDT (Eastern Daylight Time) Amendment 0004 is issued to extend the closing date from March 21, 2022 to April 04, 2022 3:00 PM EDT (Eastern Daylight Time) Amendment 0003 is issued to add the 30 count Vials per case to subject solicitation and amend solicitation pages as an attachment. Amendment 0002 is issued to extend the closing date from March 07, 2022 to March 21, 2022 3:00 PM EDT (Eastern Daylight Time) Amendment 0001 issued to solicitation for SPE2D2-21-R-0116 Levalbuterol HCL Solution to add (MG) Milligrams to the unit item description. SPE2D2-21-R-0116 Levalbuterol HCL Solution Solicitation

Version history

SAM.gov has posted 12 notices under solicitation SPE2D221R0116, oldest first.

Go deeper on this solicitation

FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.

Open the AI analysis in FedSift →

Free forever plan — no credit card. Browse solicitations without an account; sign in for AI analysis and matching.

Market context: DoD and NAICS 325412

About the buyer and the industry, not this specific solicitation. Source: USASpending.gov award data, updated nightly.

  • In fiscal year 2026, DoD obligated $70.4M across 10,537 contract actions under NAICS 325412.
  • 15 contracts worth $4.4M in this category end within the next 18 months.

DoD contracts under NAICS 325412 →

Other open solicitations in NAICS 325412

All NAICS 325412 solicitations →

More from Department of Defense

All DoD solicitations →

Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.

FedSift turns SAM.gov and USASpending data into federal BD intelligence — smart matches, recompete radar, cited AI solicitation analysis and compliance matrices.

Source data: SAM.gov (solicitations) and USASpending.gov (awards), refreshed nightly. FedSift is not affiliated with the U.S. Government.

Pricing · Privacy · Terms · support@fedsift.app

FedSift dashboard